The next chapter

We are the trusted guardian of pure breed Sandalwood Album.

Quintis has created the world's leading sustainable supply of the ancient Indian sandalwood (Santalum album) species. Through nurturing and invention, we have created a wellbeing super-ingredient: the world's purest and most potent Sandalwood Album.

With authentic DNA-verified seeds from the Mysore region in India, we replenished an endangered species by growing the noble trees in Australia’s tropical north. Under our care for nearly two decades, Quintis has 5.5 million Sandalwood Album trees covering 12,564 hectares.

Together with our partners, we are reawakening the world to the potential of this super-ingredient.

Path to success

In less than two decades we've grown to become a world leader in sandalwood production. Since the beginning we've invested in research and development from forestry and distillation through to market development in the pharmaceutical space. This innovation has been the driver of our success. These are just some of our milestones.

1980

First trials begin

Western Australia's Forest Department first began trials to grow Indian sandalwood (Santalum album) in plantations Kununurra's Ord River Irrigation Area

1997

TFS Co-founded

Learning of the potential to grow Sandalwood in plantations, Tropical Forestry Services (TFS) was founded

1999

Seeds Planted

We started our first plantings in the Ord Irrigation Area in Kununurra, Western Australia with the forester who had pioneered the early government research

2004

TFS listed

TFS - now Quintis - listed on the Australian Stock Exchange

2007

Kingston Rest

We bought the Kingston Rest property, a key location for our expansion

2008

Processing facility acquired

We acquired Mount Romance - the world's largest distiller of Sandalwood oil - facility, offering an onsite laboratory with advanced processing techniques to distil Sandalwood Album oil

2009

FORBES BEST UNDER A BILLION

TFS was featured in Forbes ‘Best under a billion Asia Pacific’ list and we began working with bio-medical researchers in the US to develop pharmaceutical uses for East Indian sandalwood oil

2010

SANTALIS PHARMACEUTICALS

We had major advancements in research and development across our operations: from forestry through to distillation

We created Santalis Pharmaceuticals Inc, a 50% joint venture company to work on the research and product development of Sandalwood Album oil as a therapeutic ingredient

2011

NATIONAL EXPANSION

We expanded nationally and established plantations in Queensland and the Northern Territory

2013

FIRST DISTILLATION

We produced and sold our first distillations of Indian sandalwood oil from Quintis-grown trees

2014

FIRST COMMERCIAL HARVEST

We completed our first commercial harvest of Sandalwood Album.

Through our 50% joint venture company Santalis Pharmaceuticals Inc., we signed a product licensing and supply agreement with Galderma a world leading global dermatology company Quintis (then TFS) joined the ASX300

2017

We Rebranded to QUINTIS

We rebranded to Quintis from TFS Corporation, reflecting our renewed operational focus on establishing a global brand sourced from a super-ingredient

2018

Funding for the Future

Following a restructure and recapitalisation, Quintis emerged as a private company in October 2018, dedicated to providing pure, potent Sandalwood Album

Quintis Sandalwood Album

Discover